These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10066007)

  • 1. Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study. French University Antidepressant Group.
    Caillard V; Rouillon F; Viel JF; Markabi S
    Acta Psychiatr Scand; 1999 Jan; 99(1):51-8. PubMed ID: 10066007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y; Judge R
    Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y; Bakker A; Dunbar G; Judge R
    Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.
    Leinonen E; Lepola U; Koponen H; Turtonen J; Wade A; Lehto H
    J Psychiatry Neurosci; 2000 Jan; 25(1):24-32. PubMed ID: 10721681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of citalopram in panic disorder.
    Wade AG; Lepola U; Koponen HJ; Pedersen V; Pedersen T
    Br J Psychiatry; 1997 Jun; 170():549-53. PubMed ID: 9330022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
    Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
    J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
    Modigh K; Westberg P; Eriksson E
    J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-finding and discontinuation study of clomipramine in panic disorder.
    Lotufo-Neto F; Bernik M; Ramos RT; Andrade L; Gorenstein C; Cordas T; Melo M; Gentil V
    J Psychopharmacol; 2001 Mar; 15(1):13-7. PubMed ID: 11277602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
    Sasson Y; Iancu I; Fux M; Taub M; Dannon PN; Zohar J
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo.
    Broocks A; Meyer T; Opitz M; Bartmann U; Hillmer-Vogel U; George A; Pekrun G; Wedekind D; Rüther E; Bandelow B
    Eur Neuropsychopharmacol; 2003 May; 13(3):153-64. PubMed ID: 12729940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial.
    Michelson D; Allgulander C; Dantendorfer K; Knezevic A; Maierhofer D; Micev V; Paunovic VR; Timotijevic I; Sarkar N; Skoglund L; Pemberton SC
    Br J Psychiatry; 2001 Dec; 179():514-8. PubMed ID: 11731354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W
    Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
    Krüger MB; Dahl AA
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S19-24. PubMed ID: 10361962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG).
    Clin Pharmacol Ther; 1999 Aug; 66(2):152-65. PubMed ID: 10460069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Romeo VM; Santoro V; Settineri S; Spina E; Zoccali RA
    J Clin Psychopharmacol; 2011 Apr; 31(2):174-9. PubMed ID: 21346614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.